Valacyclovir for HSV-2

How valacyclovir works

Valacyclovir is a prodrug. That means when you swallow it, your body converts it into acyclovir in the intestine and liver. Acyclovir is then absorbed into cells infected with the herpes virus, where viral enzymes convert it further into a compound that blocks the viral enzyme thymidine kinase.

Without thymidine kinase working properly, the virus can't replicate its DNA. No replication means no new viral particles. No new viral particles means no spreading to other cells, and no outbreak. Your immune system handles the existing infected cells over time.

The reason valacyclovir has largely replaced plain acyclovir as the first-line choice comes down to absorption. When you take oral acyclovir, only about 10-20% of it is absorbed into the bloodstream. Valacyclovir gets converted to acyclovir after absorption, producing blood levels roughly 3-5 times higher. That's why you can take valacyclovir once daily for suppression instead of twice daily.

Both drugs work on the same target. Valacyclovir is essentially a more efficient delivery system for the same active compound.

Suppressive vs. episodic treatment

There are two ways to use valacyclovir for HSV-2, and choosing between them depends on your goals and outbreak frequency.

If you're in a relationship with an HSV-negative partner, suppressive therapy is almost always the right choice. The transmission reduction is substantial and the daily 500mg dose is low enough that side effects are minimal for most people. If you're single and have infrequent outbreaks (1-2 per year), episodic treatment might be all you need.

Dosing guide

The timing of episodic treatment matters considerably. Taking valacyclovir during the prodrome (the tingling or itching that often comes before visible sores) is much more effective than starting it after sores have already developed. If you experience prodrome symptoms, that's your signal to take medication right away.

Many doctors will prescribe a supply specifically to keep on hand for this reason. You don't want to have to call a pharmacy at 11pm when you feel the prodrome starting. Ask your provider about having a course on hand.

For suppressive therapy, consistency matters more than exact timing. Take it at roughly the same time each day. Most people pair it with an existing routine like brushing teeth or eating breakfast. If you miss a dose, take it when you remember unless it's close to the next dose, in which case skip it and continue normally. Don't double up.

Effectiveness: the actual data

The foundational effectiveness data comes from a large randomized controlled trial published in the New England Journal of Medicine (Corey et al., 2004). The study enrolled couples where one partner had HSV-2 and the other was HSV-negative, and followed them for 8 months. The HSV-positive partners took either valacyclovir 500mg daily or placebo.

Results from that trial and supporting research:

• Outbreak frequency reduced by about 75% vs. placebo
• Transmission to susceptible partners occurred in 0.5% of the valacyclovir group vs. 2.2% in the placebo group (about 48% risk reduction)
• Asymptomatic viral shedding (measured by daily genital swabs) reduced by about 80%
• Symptomatic days reduced by about 85%

When combined with consistent condom use, the cumulative transmission risk reduction is approximately 75%. None of these interventions are 100% protective, but together they reduce risk substantially.

One important note: the transmission reduction was measured in heterosexual couples. There's less clinical trial data specifically on same-sex couples, though the viral shedding reduction applies regardless of sexual practices.

Side effects and safety

Valacyclovir has a genuinely good side effect profile at the doses used for HSV-2. In clinical trials, the most commonly reported side effects were headache and nausea, each in roughly 10-15% of participants. Most people who experience these find they resolve after the first week or two as the body adjusts.

What you're unlikely to experience at standard doses:

• Kidney problems (these are associated with very high doses used for other conditions, like post-transplant care)
• Neurological effects (same caveat, much higher dose territory)
• Significant drug interactions (valacyclovir has very few clinically significant interactions)
• Immune suppression (antivirals don't work like immunosuppressants)

If you have pre-existing kidney disease, your provider will adjust the dose since valacyclovir is processed by the kidneys. For people with normal kidney function, the standard dose doesn't stress the kidneys at all.

Long-term safety is well-established. Studies have followed people on continuous suppressive valacyclovir for up to 6 years without emerging safety signals. Many people take it indefinitely. It's considered one of the safer long-term medications available.

Cost and getting a prescription

Generic valacyclovir is genuinely affordable. Without insurance, you're looking at roughly $15-30 per month for 500mg once daily (30 tablets). With a GoodRx or similar discount program, prices can sometimes be as low as $12-18 at major pharmacy chains. The brand-name Valtrex is significantly more expensive and offers no clinical benefit over the generic.

Always request generic valacyclovir. There's no reason to pay the brand-name premium.

To get valacyclovir, you need a prescription from a healthcare provider. Options include:

• Your primary care doctor or OB/GYN
• A sexual health clinic or Planned Parenthood
• A telehealth service (often the most convenient option)
• An urgent care clinic if you're in the middle of an outbreak

Telehealth services like Wisp and Nurx have made getting a valacyclovir prescription quite simple. A brief online consultation, typically completed in a day, and the prescription goes to your pharmacy of choice. For routine refills, telehealth is often the most practical option.

What to expect in the first few months

Starting suppressive therapy changes the experience of HSV-2 meaningfully for most people. Here's a rough timeline of what people typically report:

Weeks 1-2: Some people experience mild nausea or headache as the body adjusts. Most people notice nothing at all. If you're currently in an outbreak, the medication will help shorten it, though it takes a day or two to fully kick in.

Month 1: Outbreak frequency starts declining. Many people who previously had frequent outbreaks notice fewer by their first monthly refill. The medication is working even if you don't notice it day-to-day.

Months 2-3: For most people, the pattern is settling into something close to the trial data. If you were having frequent outbreaks, they're typically reduced by about 75%. Some people on suppressive therapy go entire years without an outbreak.

Long-term: Suppressive therapy is not something you're locked into forever. Some providers will suggest re-evaluating after a year or two, especially if outbreak frequency has naturally declined over time (which it often does as the immune system adapts to the virus). The decision to stay on suppressive therapy should be based on your current outbreak pattern, relationship status, and personal preferences.

Valacyclovir vs. acyclovir vs. famciclovir

All three FDA-approved antivirals for HSV-2 work on the same basic mechanism. The differences are practical rather than fundamental:

Valacyclovir is often chosen first because of the once-daily convenience. Acyclovir is a reasonable choice if cost is the primary concern. Famciclovir is an alternative for people who don't tolerate the other two, though it's less commonly prescribed.

Related: Acyclovir guide | Compare all antivirals | Treatment overview | Transmission risk data